UFP Technologies Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
13.4%projected annual EPS growth
Analyst Coverage
2analysts covering
FY Revenue (est.)
$657.8Mnext fiscal year
FY EPS (est.)
$10.62next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 2 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Medical Sales Growth Quarterly590.0%Target: 12% to 18% total revenue growth
Gross Margin Quarterly2,880.0%Target: 28% to 31%
Adjusted Operating Margin Quarterly1,670.0%Target: 17% to 20%
Watch Items
- Cybersecurity Remediation and CostsTrigger: Any material un-reimbursed costs or further operational delays following the February 14, 2026 ransomware attack.Action: Monitor subsequent quarterly filings (10-Q) and insurance reimbursement disclosures.
- Labor Inefficiencies at AJRTrigger: Persistent drag on gross margins due to labor inefficiencies at the AJR facility.Action: Track management commentary on gross margin progression and operational stabilization.
- Non-Medical Segment SoftnessTrigger: A decline exceeding 15% in non-medical sales due to strategic exits of lower-margin businesses.Action: Evaluate the pace of medical program ramp-ups to ensure they offset non-medical declines.
Research as of 20 Jun 2026